Fundraising FoxIntracellular Therapies
1 known investors
Find your way into Intracellular Therapies
Sign up to see every warm intro you have to Intracellular Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Intracellular Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.
Founders & leadership
PG
Paul Greengard
Investors · 1
Frequently asked questions
- What does Intracellular Therapies do?
- A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.
- Who founded Intracellular Therapies?
- Intracellular Therapies was founded by Paul Greengard.
- Who are Intracellular Therapies's investors?
- Intracellular Therapies's investors include Scientia Ventures.